Strategia can help streamline your company’s drug development efforts
Our core team and global partners offer a wide range of expertise in drug development, strategy, manufacturing, and more.
Our team of experts collectively has more than 200 years of experience and special expertise in global drug and biologic development, from discovery and proof-of-concept to worldwide approval and life cycle management. This puts us in a unique position to efficiently assist with global drug development strategies and execution. We have global expertise in small and large molecule development as well as biologics development (antibodies, recombinant proteins, therapeutic cancer vaccines, immunotherapy, gene therapies and combination products) in solid tumors and hematologic malignancies, anti-infectives, retinal diseases and asthma in multiple countries and with regulatory agencies worldwide. We are ready and able to assist small and large pharmaceutical and/or biologics companies with all, or a portion, of your global drug development needs.
Strategia Therapeutics has developed a full suite of discovery and GLP preclinical capabilities that reduce the need for large infrastructure. We tailor our approach to the unique needs of a particular program, and recruit partners with expertise specific to a particular therapy. By streamlining the R&D process, we deliver products in a timely, efficient and cost-effective manner. Our pharmacology, pharmacokinetic and pharmacodynamics experts have more than 200 years’ experience in developing new therapeutics for small and large molecules, immunotherapeutics and diagnostic agents. All are well-versed in medicinal chemistry, bioanalytics, data analysis, interpretation, and regulated study report preparation.
Strategia Therapeutics reviews and selects optimal manufacturing capabilities for each therapy under consideration, choosing among small molecule, large molecule, biologic (antibody, recombinant protein, gene therapy), or combination product cGMP manufacturers.
At Strategia Therapeutics, quality is a core component of our development strategy. We coordinate all quality assurance (QA) activities and assess each specific project to ensure the required resources and expertise are efficiently applied. Our procedures are unique in that they require cross-functional communication and management attention to our quality responsibilities. For each project, we prepare a comprehensive quality plan that coordinates a suite of quality services including auditing, document reviews, training, and corrective action (CAPA) plans.
Strategia Therapeutics facilitates drug development by integrating preclinical, translational and clinical expertise and resources. By working with our global partners under collaborative agreements, we bridge the gap between industry and academia, lower development costs, and shorten the timeframe needed to create effective drugs for patients. Our specific alliance with the prestigious M.D. Anderson Cancer Center gives us unique capabilities to optimize and mobilize oncology translational studies through clinical development, conduct efficient and high quality clinical trials, and obtain robust proof of concept data that helps establish rapid global approval. We also work with other academic and community practice institutions to serve your drug development needs.
Strategia Therapeutics has a full suite of consulting services for global business development, including:
Strategia Therapeutics also is available for risk-sharing opportunities based on flexible terms, including a buy-back option once a therapy reaches proof-of-concept or other development milestones.
Strategia Therapeutics has experience developing, managing and optimizing global drug development programs from late discovery to translational research to first-in-man proof-of-concept studies through market approval and life cycle management. Our deep expertise in developing drugs and biologics to markets worldwide puts Strategia in a unique position to serve your needs.
Our global network of resources and deep experience in drug/biologic development ensures your goals are met efficiently, with an optimal budget and timeline. Our program management can serve as the strategic lead for your project during all stages of development; or we can play a supporting role to your internal project management team, providing consultation, guidance, and execution on time and within budget. In this management role, Strategia Therapeutics can act as single point of contact to determine your research and development strategy, execute the strategy, contract with CROs and CMOs, coordinate both operational and reporting activities, and keep your team dynamically updated on the progress of the project.